RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study

      한글로보기

      https://www.riss.kr/link?id=A105961352

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: The recent trend in breast cancer treatment is to minimize axillary dissection. However, no pattern of axillary metastasis has been precisely established. The purpose of this study was to evaluate the metastatic lymphatic pattern using near-infrared fluorescence imaging with indocyanine green (ICG) in breast cancer with cytologically proven axillary metastasis.
      Methods: This was a prospective single-center study. We evaluated 147 patients with breast cancer involving cytologically proven axillary metastasis, and compared physiological and nonphysiological lymphatic metastasis. Results: We performed lymphatic mapping for 64 patients who exhibited level II lymphatic flow on near-infrared fluorescence imaging with ICG, and found that all had axillary metastasis: 51 patients who did not receive neoadjuvant chemotherapy (NAC) and 13 patients post- NAC. Of patients who did not receive NAC, 32 had physiological lymphatic metastasis and 19 had nonphysiological lymphatic metastasis. The risk factors for nonphysiological lymphatic metastasis were age ≥55 years, high Ki-67 index (>20%), and perinodal extension in both univariate and multivariate analysis (p<0.05). Conclusion: Patients with identified risk factors in cytologically- proven axillary metastasis who did not receive NAC may have nonphysiological lymphatic metastasis.
      번역하기

      Purpose: The recent trend in breast cancer treatment is to minimize axillary dissection. However, no pattern of axillary metastasis has been precisely established. The purpose of this study was to evaluate the metastatic lymphatic pattern using near-i...

      Purpose: The recent trend in breast cancer treatment is to minimize axillary dissection. However, no pattern of axillary metastasis has been precisely established. The purpose of this study was to evaluate the metastatic lymphatic pattern using near-infrared fluorescence imaging with indocyanine green (ICG) in breast cancer with cytologically proven axillary metastasis.
      Methods: This was a prospective single-center study. We evaluated 147 patients with breast cancer involving cytologically proven axillary metastasis, and compared physiological and nonphysiological lymphatic metastasis. Results: We performed lymphatic mapping for 64 patients who exhibited level II lymphatic flow on near-infrared fluorescence imaging with ICG, and found that all had axillary metastasis: 51 patients who did not receive neoadjuvant chemotherapy (NAC) and 13 patients post- NAC. Of patients who did not receive NAC, 32 had physiological lymphatic metastasis and 19 had nonphysiological lymphatic metastasis. The risk factors for nonphysiological lymphatic metastasis were age ≥55 years, high Ki-67 index (>20%), and perinodal extension in both univariate and multivariate analysis (p<0.05). Conclusion: Patients with identified risk factors in cytologically- proven axillary metastasis who did not receive NAC may have nonphysiological lymphatic metastasis.

      더보기

      참고문헌 (Reference)

      1 Chi C, "Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients:from preclinical evaluation to clinical validation" 8 : e83927-, 2013

      2 Alford R, "Toxicity of organic fluorophores used in molecular imaging : literature review" 8 : 341-354, 2009

      3 Schaafsma BE, "The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery" 104 : 323-332, 2011

      4 Wang H, "Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression" 33 : 1943-1950, 2012

      5 Gennaro M, "Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema" 39 : 1341-1345, 2013

      6 Donker M, "Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial" 15 : 1303-1310, 2014

      7 van der Loo EM, "Less operations required due to perioperative frozen section examination of sentinel nodes in 275 breast cancer patients" 145 : 1986-1991, 2001

      8 Pitsinis V, "Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer" 24 : 375-379, 2015

      9 Hirche C, "ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer" 121 : 373-378, 2010

      10 Gilmore DM, "Effective low-dose escalation of indocyanine green for nearinfrared fluorescent sentinel lymph node mapping in melanoma" 20 : 2357-2363, 2013

      1 Chi C, "Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients:from preclinical evaluation to clinical validation" 8 : e83927-, 2013

      2 Alford R, "Toxicity of organic fluorophores used in molecular imaging : literature review" 8 : 341-354, 2009

      3 Schaafsma BE, "The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery" 104 : 323-332, 2011

      4 Wang H, "Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression" 33 : 1943-1950, 2012

      5 Gennaro M, "Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema" 39 : 1341-1345, 2013

      6 Donker M, "Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial" 15 : 1303-1310, 2014

      7 van der Loo EM, "Less operations required due to perioperative frozen section examination of sentinel nodes in 275 breast cancer patients" 145 : 1986-1991, 2001

      8 Pitsinis V, "Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer" 24 : 375-379, 2015

      9 Hirche C, "ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer" 121 : 373-378, 2010

      10 Gilmore DM, "Effective low-dose escalation of indocyanine green for nearinfrared fluorescent sentinel lymph node mapping in melanoma" 20 : 2357-2363, 2013

      11 Giuliano AE, "Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis : the ACOSOG Z0011(Alliance)randomized clinical trial" 318 : 918-926, 2017

      12 Zhang X, "Diagnostic performance of indocyanine green-guided sentinel lymph node biopsy in breast cancer: a meta-analysis" 11 : e0155597-, 2016

      13 김이삭, "Development of a Nomogram to Predict N2 or N3 Stage in T1–2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy" 한국유방암학회 20 (20): 270-278, 2017

      14 Jung SY, "Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial" 21 : 1254-1259, 2014

      15 Guo J, "Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study" 15 : 196-, 2017

      16 Dewis R, "Breast Cancer: Diagnosis and Treatment: An Assessment of Need" National Collaborating Centre for Cancer 13-35, 2009

      17 Sugie T, "A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer" 2 : 713-720, 2010

      18 Hokimoto N, "A novel color fluorescence navigation system for intraoperative transcutaneous lymphatic mapping and resection of sentinel lymph nodes in breast cancer : comparison with the combination of gamma probe scanning and visible dye methods" 94 : 99-106, 2018

      19 Wishart GC, "A feasibility study(ICG-10)of indocyanine green(ICG)fluorescence mapping for sentinel lymph node detection in early breast cancer" 38 : 651-656, 2012

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-04-06 학술지명변경 외국어명 : Journal of Korean Breast Cancer -> Journal of Breast Cancer KCI등재
      2011-03-23 학술지명변경 외국어명 : Journal of Korean Breast Cancer -> 미등록 KCI등재
      2011-03-04 학술지명변경 한글명 : 한국유방암학회지 -> Journal of Breast Cancer KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2008-01-01 평가 SCIE 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.99 0.19 1.31
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.96 0.77 0.448 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼